Market Overview

A Peek Into The Market Before The Trading Starts

Share:
A Peek Into The Market Before The Trading Starts
Related JNJ
S&P 500 Index Futures Trading Higher
ETFs For The Next Pharma Takeover Candidates
Dividend Funds With Adaptive Allocation Generate More Income Than The Best Dividend Aristocrats (Seeking Alpha)
Related TZYM
Tranzyme, Ocera Announce Merger Agreement
A Peek Into The Market Before The Trading Starts

Pre-open movers US stock futures are mostly flat this morning, as investors are awaiting jobs data. Futures for the Dow Jones Industrial Average dropped 4 points to 13,315.00 and S&P 500 index futures rose 0.40 points to 1,454.00. Nasdaq 100 futures gained 2.75 points to 2,728.25.

A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index fell 0.24%, London's FTSE 100 Index dropped 0.13%, German DAX 30 Index declined 0.44% and French CAC 40 Index fell 0.27%.

Asian markets ended mixed, with Japan's Nikkei Stock Average rising 2.82%, China's Shanghai Composite gaining 0.35% and Australia's S&P/ASX 200 Index dropping 0.39%. Hong Kong's Hang Seng Index fell 0.29% and India's Sensex rose 0.10%.

Broker Recommendation Analysts at Deutsche Bank upgraded Johnson & Johnson (NYSE: JNJ) from “hold” to “buy.” The target price for Johnson & Johnson has been raised from $75 to $82.

Johnson & Johnson shares gained 0.52% to $71.11 in pre-market trading.

Breaking news

  • Tranzyme Pharma (NASDAQ: TZYM) today announced the successful completion of its chemistry-based drug discovery collaboration with Bristol-Myers Squibb (NYSE: BMY). To read the full news, click here.
  • Concord Medical Services (NYSE: CCM) announced today that it has closed the acquisition of 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center. To read the full news, click here.
  • UTStarcom Holdings (NASDAQ: UTSI) today announced the preliminary results of its previously announced tender offer for the purchase of up to 25,000,000 of its ordinary shares at a price of $1.20 per share, which expired at 5:00 P.M., New York City time, on Thursday, January 3, 2013. To read the full news, click here.
  • PostRock Energy (NASDAQ: PSTR) today announced a $29.7 million capital budget for 2013. To read the full news, click here.

Posted-In: Deutsche Bank US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Related Articles (BMY + CCM)

Get Benzinga's Newsletters